Patients with rheumatoid arthritis have a chance to participate in a clinical trial for a medicine doctors say could be cheaper and more convenient.
Currently, most patients with RA either give themselves painful shots or have to sit through inconvenient IV infusions for treatment.
The Metroplex Clinical Research Center in Dallas is studying a new pill patients simply take twice a day.
"The fact that it's oral makes it much more convenient, and it should be much cheaper than the other biologics that we use," said Dr. Roy Fleischmann, M.D., co-medical director, Metroplex Clinical Research Center.
Cheryl Hathaway is a patient in the trial.
"I got to the point where it was difficult to even stand-up," she said of her 15 year battle with RA.
After four months in the trial, she doesn't know if she's on the active drug or a placebo. Either way, she says she feels much better.
The study is being conducted in conjunction with Pfizer. More patients are needed.
Click here to find out if you qualify.